Richard Edmondson

The University of Manchester

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

Ranjit Manchanda

Professor of Gynaecological Oncology

UNITED KINGDOM

View details

Carien Creutzberg

Professor of Radiation Oncology

Leiden University Medical Center

NETHERLANDS

View details

Iain McNeish

Imperial College London

UNITED KINGDOM

View details

Carole Cummins

University of Birmingham

UNITED KINGDOM

View details

Robert Morgan

The University of Manchester

UNITED KINGDOM

View details

Marco de Bruyn

Assistant professor

University Medical Center Groningen

NETHERLANDS

View details

John Bowes

The University of Manchester

UNITED KINGDOM

View details

Nicola Flaum

The University of Manchester

UNITED KINGDOM

View details

Gordon Jayson

The University of Manchester

UNITED KINGDOM

View details

Thomas Walker

The University of Manchester

UNITED KINGDOM

View details

Laura Woodhouse

The University of Manchester

UNITED KINGDOM

View details

Emma Woodward

Manchester University NHS Foundation Trust

UNITED KINGDOM

View details

Pamela M Pollock

AUSTRALIA

View details

Sudha Sundar

University of Birmingham

UNITED KINGDOM

View details

Darren Flynn

Professor

Northumbria University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Richard Edmondson

Research Interests

Explore related searches

Contact this professor

Articles (18)

Borderline ovarian tumours

The management of vaginal prolapse and stress incontinence mesh complications in a quaternary mesh complications service in the United Kingdom (U.K): a 5-year observational study

Patient and clinician priorities for information on treatment outcomes for advanced ovarian cancer: a Delphi exercise

Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer

British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines

The DNA damage response in advanced ovarian cancer: functional analysis combined with machine learning identifies signatures that correlate with chemotherapy sensitivity and patient outcome

MDT practice determines treatment pathway for patients with advanced ovarian cancer: A multi-centre observational study

A three protein signature fails to externally validate as a biomarker to predict surgical outcome in high-grade epithelial ovarian cancer

Is reflex germline BRCA1/2 testing necessary in women diagnosed with non-mucinous high-grade epithelial ovarian cancer aged 80 years or older?

British Gynaecological Cancer Society Recommendations for Evidence Based, Population Data Derived Quality Performance Indicators for Ovarian Cancer

Analysis of Anxiety, Depression and Fear of Progression at 12 Months Post-Cytoreductive Surgery in the SOCQER-2 (Surgery in Ovarian Cancer—Quality of Life Evaluation Research) Prospective, International, Multicentre Study

Engineering strategies to optimise adoptive cell therapy in ovarian cancer

Optimisation of polygenic risk scores in BRCA1/2 pathogenic variant heterozygotes in epithelial ovarian cancer

p53 immunohistochemistry in endometrial cancer

High detection rate from genetic testing in BRCA-negative women with familial epithelial ovarian cancer

The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2

Investigating the Impact of Ultra-Radical Surgery on Survival in Advanced Ovarian Cancer Using Population-Based Data in a Multicentre UK Study

Predicting the likelihood of a BRCA1/2 pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer

Collaborators (15)

Ranjit Manchanda

Carien Creutzberg

Iain McNeish

Carole Cummins

Robert Morgan

Marco de Bruyn

John Bowes

Nicola Flaum

Gordon Jayson

Thomas Walker

Laura Woodhouse

Emma Woodward

Pamela M Pollock

Sudha Sundar

Darren Flynn

Make your next move.